These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 16286529

  • 21. Metabolic syndrome and high-sensitivity C-reactive protein in Cubans.
    Huffman FG, Gomez GP, Zarini GG.
    Ethn Dis; 2009; 19(2):115-20. PubMed ID: 19537220
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Raised C-reactive protein levels in patients with recent onset type 1 diabetes.
    Picardi A, Valorani MG, Vespasiani Gentilucci U, Manfrini S, Ciofini O, Cappa M, Guglielmi C, Pozzilli P, IMDIAB Group.
    Diabetes Metab Res Rev; 2007 Mar; 23(3):211-4. PubMed ID: 16832831
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. C-reactive protein associated with coronary artery disease in Iranian patients with angiographically defined coronary artery disease.
    Kazemi-Bajestani SM, Ghayour-Mobarhan M, Ebrahimi M, Moohebati M, Esmaeili HA, Ferns GA.
    Clin Lab; 2007 Mar; 53(1-2):49-56. PubMed ID: 17323825
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Associations of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus.
    Mojiminiyi OA, Abdella NA.
    Scand J Clin Lab Invest; 2007 Mar; 67(2):215-25. PubMed ID: 17366001
    [Abstract] [Full Text] [Related]

  • 28. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS, Morrow DA, Jablonski KA, Rice MM, Warnica JW, Domanski MJ, Hsia J, Gersh BJ, Rifai N, Ridker PM, Pfeffer MA, Braunwald E, PEACE Investigators.
    Circulation; 2007 Mar 27; 115(12):1528-36. PubMed ID: 17372173
    [Abstract] [Full Text] [Related]

  • 29. Association between serum values of C-reactive protein and cytokine production in whole blood of patients with type 2 diabetes.
    Castoldi G, Galimberti S, Riva C, Papagna R, Querci F, Casati M, Zerbini G, Caccianiga G, Ferrarese C, Baldoni M, Valsecchi MG, Stella A.
    Clin Sci (Lond); 2007 Jul 27; 113(2):103-8. PubMed ID: 17362204
    [Abstract] [Full Text] [Related]

  • 30. Body iron stores in relation to the metabolic syndrome, glycemic control and complications in female patients with type 2 diabetes.
    Mojiminiyi OA, Marouf R, Abdella NA.
    Nutr Metab Cardiovasc Dis; 2008 Oct 27; 18(8):559-66. PubMed ID: 18063352
    [Abstract] [Full Text] [Related]

  • 31. C-reactive protein is a strong independent predictor of death in type 2 diabetes: association with multiple facets of the metabolic syndrome.
    Linnemann B, Voigt W, Nobel W, Janka HU.
    Exp Clin Endocrinol Diabetes; 2006 Mar 27; 114(3):127-34. PubMed ID: 16636979
    [Abstract] [Full Text] [Related]

  • 32. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
    Dullaart RP, de Vries R, Sluiter WJ, Voorbij HA.
    Clin Endocrinol (Oxf); 2009 Feb 27; 70(2):221-6. PubMed ID: 18505467
    [Abstract] [Full Text] [Related]

  • 33. The levels of circulating markers of atherosclerosis and inflammation in subjects with different degrees of body mass index: Soluble CD40 ligand and high-sensitivity C-reactive protein.
    Guldiken S, Demir M, Arikan E, Turgut B, Azcan S, Gerenli M, Tugrul A.
    Thromb Res; 2007 Feb 27; 119(1):79-84. PubMed ID: 16476470
    [Abstract] [Full Text] [Related]

  • 34. Association between C-reactive protein and clinical outcomes in peritoneal dialysis patients.
    Avram MM, Fein PA, Paluch MM, Schloth T, Chattopadhyay J.
    Adv Perit Dial; 2005 Feb 27; 21():154-8. PubMed ID: 16686309
    [Abstract] [Full Text] [Related]

  • 35. Do albuminuria and hs-CRP add to the International Diabetes Federation definition of the metabolic syndrome in predicting outcome?
    van der Velde M, Bello AK, Brantsma AH, El Nahas M, Bakker SJ, de Jong PE, Gansevoort RT.
    Nephrol Dial Transplant; 2012 Jun 27; 27(6):2275-83. PubMed ID: 22231032
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [High-sensitive C-reactive protein and Type 2 diabetic nephropathy].
    Liao L, Lei MX, Chen HL, Wu J, Guo LJ.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec 27; 29(6):627-30. PubMed ID: 16114543
    [Abstract] [Full Text] [Related]

  • 38. Serum adiponectin confers little protection against diabetes and hypertension in Turkish men.
    Onat A, Hergenç G, Can G, Küçükdurmaz Z.
    Obesity (Silver Spring); 2009 Mar 27; 17(3):564-70. PubMed ID: 19238142
    [Abstract] [Full Text] [Related]

  • 39. The association between upper gastrointestinal lesions and high-sensitivity C-reactive protein in coronary artery disease patients.
    Fabijanić D, Banić M, Kardum D, Sutlić Z, Simunić M, Bonacin D, Romić Z, Petricusić L, Kujundzić M.
    Med Sci Monit; 2009 Feb 27; 15(2):CR45-50. PubMed ID: 19179966
    [Abstract] [Full Text] [Related]

  • 40. Association of endogenous sex hormone with C-reactive protein levels in middle-aged and elderly men.
    Nakhai Pour HR, Grobbee DE, Muller M, van der Schouw YT.
    Clin Endocrinol (Oxf); 2007 Mar 27; 66(3):394-8. PubMed ID: 17302874
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.